Analgesics in Bosnia and Herzegovina is set to demonstrate resilience and continued growth, outperforming expectations despite a declining population. Retail e-commerce and digital transformation are redefining access and purchase behaviour, led by platforms that have embedded rapid delivery and omnichannel solutions as essential routes to market, driving both consumer satisfaction and structural value gains. The shift towards focused product portfolios, exemplified by the consolidation around high-velocity SKUs, and the marked consumer preference for non-opioid, plant-based topical options, are prompting brands to streamline supply chains and differentiate through efficacy and simplicity. In this context, analgesics remains attractive due to stable demand, innovation in digital distribution and evolving consumer preferences, although future success is expected to depend on the ability to adapt to changing retail dynamics, invest in non-opioid innovation and maintain strong pharmacist engagement. Companies that prioritise clear brand identity, digital access and a focused product mix are best positioned to secure growth.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Bosnia and Herzegovina with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Bosnia and Herzegovina, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Bosnia and Herzegovina report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Bosnia and Herzegovina?
- Which are the leading brands in Analgesics in Bosnia and Herzegovina?
- How are products distributed in Analgesics in Bosnia and Herzegovina?
- How has the regulatory and operating environment for Analgesics changed in Bosnia and Herzegovina?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Glovo's online delivery reshapes pain relief access
Neofen rapid replaces complexity with focused pain relief solutions
Himalaya Rumalaya Gel drives demand for non-opioid pain management
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Self-medication set to drive growth amid population decline
Combination analgesics to reshape pain management
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Teva Pharmaceutical maintains lead as fragmentation drives competition and opportunity
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintain influence as key point of sale
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!